Circulating tumour DNA as a noninvasive biomarker in melanoma [ 2016 - 2019 ]

Research Grant

Researchers: A/Pr Sarah-Jane Dawson (Principal investigator) ,  Prof Mark Shackleton

Brief description The expanding repertoire of treatment options in melanoma is bringing into focus the need for improved ways to accurately monitor treatment responses and guide treatment decisions. Many cancers shed small amounts of DNA (ctDNA) into the bloodstream and changes in ctDNA levels have potential to be used as specific markers of response to cancer therapy. This project will evaluate if ctDNA can be used as a form of ‘liquid biopsy’ to guide treatment decisions in patients with melanoma.

Funding Amount $AUD 1,341,140.17

Funding Scheme Project Grants

Notes Standard Project Grant